CEL-SCI Corp
Biotechnology
Healthcare
CVM
4.15 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
9.06
52 week high
38.40
high
9.25
52 week low
0.00
low
8.63
growth
-73.36 %
previous Close
8.99
P/E ratio
-6
market cap
58.29 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-5.66 M
13.81 %
eps
-1.36 %
41.69 %
eps surprise
0.00 %
net profit margin
-566470400.00 %
0.00 %
operating incoming
-5.49 M
14.16 %
net change in cash
-131.45 K
95.11 %
cash on hand
1.79 M
-6.83 %
cost of revenue
959 K
0.00 %
top top